missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD94 Monoclonal Antibody (3G2)

Descripción
MA5-15818 targets CD94 in indirect ELISA, WB applications and shows reactivity with Human samples. The MA5-15818 immunogen is purified recombinant fragment of human CD94 expressed in E. Coli. MA5-15818 detects CD94 which has a predicted molecular weight of approximately 21kDa.
Natural killer (NK) cells, like CD94, are a distinct lineage of lymphocytes that mediate cytotoxic activity and secrete cytokines upon immune stimulation. Several genes of the C-type lectin superfamily, including members of the NKG2 family, are expressed by NK cells and may be involved in the regulation of NK cell function. KLRD1 (CD94) is an antigen preferentially expressed on NK cells and is classified as a type II membrane protein because it has an external C terminus. Three transcript variants encoding two different isoforms have been found for this gene.
Especificaciones
Especificaciones
| Antígeno | CD94 |
| Aplicaciones | ELISA, Western Blot |
| Clasificación | Monoclonal |
| Clon | 3G2 |
| Concentración | Conc. Not Determined |
| Conjugado | Unconjugated |
| Formulación | ascites with 0.03% sodium azide |
| génica | KLRD1 |
| N.º de referencia del gen | Q13241 |
| Alias de gen | Cd94; CD94 antigen; CD94 antigen (located within the rat natural killer gene complex); killer cell lectin like receptor D1; Killer cell lectin-like receptor subfamily D member 1; killer cell lectin-like receptor subfamily D, member 1; killer cell lectin-like receptor, subfamily D, member 1; KLRD1; KP43; natural killer cell receptor; natural killer cells antigen CD94; NK cell receptor |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?